Randy Thurman

Chairman and CEO, VIASYS Healthcare, Inc.

Mr. Thurman, Economics ‘71, has served as Chief Executive Officer of VIASYS Healthcare, Inc. since April 2001 and became Chairman of the Board upon the public offering in November 2001. From 1996 to April 2001, Mr. Thurman served as Chairman and Chief Executive Officer of Strategic Reserves LLC, a privately held company providing funding and strategic direction to healthcare technology companies. From 1993 to 1996, Mr. Thurman was Chairman and CEO of Corning Life Sciences Inc., which was a global leader in clinical laboratory testing, pharmaceutical research and esoteric reference testing. Concurrent with the aforementioned positions, Mr. Thurman served as Chairman of the Board of Enzon Pharmaceuticals from 1994 to 2001 (Nasdaq: ENZN). From 1984 to 1993, Mr. Thurman held various positions at Rhone-Poulenc Rorer Pharmaceuticals, Inc., a global pharmaceutical company, ultimately as its President. Mr. Thurman also serves as Lead Director of Valeant Pharmaceuticals International (NYSE: VRX) and as a director of Closure Medical Corporation (Nasdaq: CLSR).

VIASYS Healthcare Inc. is a global market leader in health-care technology--a distinction that is built on a solid history of innovation, superior product performance, and a commitment to customer service. VIASYS Healthcare comprises many well-established companies that are each recognized for market leadership. These companies specialize in developing, manufacturing, marketing, and servicing high-technology medical devices that are used in respiratory care, neurology, vascular medicine, critical care, and the medical and surgical product markets. Their products are used to assist physicians in the diagnosis and treatment of cardiopulmonary, digestive, neurological, respiratory, and vascular disorders for neonatal, pediatric, and adult patients. Customers of VIASYS Healthcare include hospitals, alternate care sites, clinical laboratories, and private physicians in over 100 countries.